Model N Introduces New Rebate Enhancement, as Pharma Companies Prepare for Impact from the Inflation Reduction Act

SAN MATEO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Model N (NYSE:MODN), the leader in revenue optimization and compliance has introduced a critical product enhancement that supports evolving compliance needs around the Inflation Reduction Act (IRA). The company has introduced a new Medicare Part D inflation rebate-per-unit, ensuring pharma manufacturers remain compliant with impending IRA regulation and avoid significant revenue loss. "The Inflation Reduction Act introduces sweeping changes for drug pricin ...